Meet Our Team
Kipp Weiskopf, M.D., Ph.D.
Principal Investigator
Kipp Weiskopf, M.D., PhD, is a Valhalla Fellow at Whitehead Institute for Biomedical Research in Cambridge, MA. He is a leader in the field of macrophage-directed therapies and oversees a research laboratory that studies novel macrophage and myeloid immune checkpoints in the context of cancer and other life-threatening diseases. Dr. Weiskopf earned his medical and graduate degrees at Stanford University. As a member of Dr. Irving Weissman’s laboratory, he characterized the CD47/SIRPa interaction as an immune checkpoint that regulates macrophages in the tumor microenvironment. He engineered therapies that stimulate macrophages to attack tumors and showed these could be effective for many types of cancer.
Dr. Weiskopf is an inventor on over 20 issued U.S. patents pertaining to macrophage-directed therapies. He co-founded ALX Oncology, a biotech company that is investigating macrophage-directed therapies in multiple clinical trials for cancer. Other technology that Dr. Weiskopf invented has been licensed to Forty Seven, Inc. (acquired by Gilead). More recently, he co-founded DEM Biopharma and Solu Therapeutics to create novel therapies for cancer and other life-threatening diseases.
Dr. Weiskopf is also an Affiliated Research Fellow of the Koch Institute for Integrative Cancer Research at MIT, and he maintains a clinical appointment as a physician at Dana-Farber Cancer Institute in Boston, MA. He previously completed his medical training in the Internal Medicine Residency Program at Brigham and Women’s Hospital and is board certified in Internal Medicine. He has been awarded a Winston Churchill Scholarship, the Harold M. Weintraub Graduate Student Award, first place in the Collegiate Inventors Competition, an ASCO Young Investigator Award, the AACR-AstraZeneca Career Development Award for Physician-Scientists, in Honor of José Baselga, and a Department of Defense Peer-Reviewed Cancer Research Program Career Development Award. Dr. Weiskopf previously earned a B.A. from Amherst College and an M.Phil. in genetics from University of Cambridge.
-
Anna Meglan
Technical Assistant I
-
Juliano Ribeiro
Technical Assistant I
-
Jasmine Blandin, M.Sc.
M.D. student, Médecine Sorbonne Université
Ph.D. student, Université Paris-Saclay -
Kyle Vaccaro
Technical Assistant II
-
Thomas Wienclaw
Technical Assistant I
-
Mickey Sloat
M.D./Ph.D. student, Harvard/MIT HST Program
-
Asaf Maoz, M.D.
Physician, Medical Oncology, Dana-Farber Cancer Institute
-
Alexandra Schnell, Ph.D.
Postdoctoral Scholar
Co-mentor: Dr. Jonathan Weissman -
Ferenc Reinhardt
Animal Technician
-
Donna Hicks
Administrative Lab Manager
Former Lab Members
-
Eloise Froelich
Intern
University of Colorado Boulder
-
José Velarde, A.B.
Technical Assistant I
Current position: M.D., Ph.D. student, University of Pennsylvania
-
Juliet Allen, B.S.
Technical Assistant II
Current position: M.D. student, Columbia University
-
Mriganka Mandal
Undergraduate Research Opportunities Program (UROP)
MIT
-
Nivi Nambrath
Undergraduate Research Opportunities Program (UROP)
Wellesley College
